Xeris Pharmaceuticals | GJELD



Debt Endring Dato
Adcock Ingram Holdings ZAR 280.54M 199.53M 2024-06
Celltrion KRW 2.19T 18.16B 2024-09
Cspc Pharmaceutical CNY 507.33M 118.46M 2024-12
Dianthus Therapeutics USD 1.49M 1.49M 2024-12
Ecofibre AUD 25.49M 285K 2024-06
Eli Lilly USD 33.64B 2.52B 2024-12
Kangmei Pharma CNY 253.72M 1.04B 2024-09
Knight Therapeutics CAD 58.22M 109K 2024-09
Laboratorios Farma EUR 114.41M 6.75M 2024-12
Malin Corporation EUR 0 100K 2024-06
Medical Developments International AUD 2.29M 140K 2024-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 44.74M 12.56M 2024-12
Pacira USD 585.32M 2.04M 2024-12
Perrigo USD 3.62B 1.14B 2024-12
Pharma Mar EUR 51.08M 1.99M 2024-12
Qiagen NV USD 1.39B 528.29M 2024-12
Sartorius EUR 4.53B 98.7M 2024-09
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
Tilray USD 351.72M 15.26M 2024-11
Zz Pientze Pharmaceu 1.18B 115.85M 2024-09



Xeris Pharmaceuticals GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.